Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
- The company is also counting on newer medicines to lessen its dependence on aging blockbuster drugs
- Pfizer has said it expects to return to stronger growth after 2028
Pfizer
Belgian court throws out Covid vaccine case against EU chief
UK regulator approves updated Pfizer-BioNTech COVID vaccine
US promises five million more Pfizer doses as Christmas present to Pakistan
US shipping 3 mln doses of Pfizer COVID-19 vaccine to Pakistan — official
Special